Home >Medical Device Software Development
Medical Device Software Development
Build or modernize medical device software around its intended use, safety responsibilities, device and data interfaces, software lifecycle, traceability, verification and validation, cybersecurity, and post-release change controls – not around a generic healthcare feature list.
For MedTech companies, digital-health product teams, healthcare organizations, and device manufacturers, we design software boundaries across Software as a Medical Device (SaMD), device-connected applications, clinical interfaces, device-data services, and supporting cloud or integration layers while keeping regulatory, clinical, quality-management, and evidence responsibilities explicit for the target product and market.
Founded
Technology Experts
Digital Solutions Launched
Enterprise Projects
Countries Served
When a Healthcare Prototype Becomes a Medical Device Software Program
Medical-device software projects become difficult when engineering moves faster than the intended-use, risk, evidence, and quality-system decisions that define the product. A technically impressive prototype can still be expensive to productize if its requirements, interfaces, hazards, versions, and test evidence are not structured from the beginning.
The Product Category Is Decided by Marketing Language
Calling a product a wellness app, clinical assistant, AI platform, or medical device does not establish its regulatory responsibility. The software function, intended medical purpose, users, patient population, inputs, outputs, and how people may rely on the result should be defined first. Product classification and regulatory strategy should then be confirmed by the appropriate regulatory specialists.
A Prototype Exists but the Evidence Chain Does Not
Fast prototyping can validate a concept, but production medical-device software may need documented requirements, architecture decisions, risk controls, configuration records, review history, verification evidence, validation evidence, and controlled release records. Retrofitting that chain after the codebase is mature is far more difficult than planning it with development.
Risk Management and Software Requirements Live in Separate Documents
A hazard analysis is useful only when risk-control requirements reach the implementation and test plan. If a safety requirement changes, the team should be able to see which architecture, code, interface, test case, and released version are affected rather than manually reconstructing the relationship during a review.
Device, App, Cloud, and Algorithm Versions Drift Independently
Connected products may include device hardware, firmware, mobile or desktop software, cloud services, clinical interfaces, and algorithm or model versions. Compatibility should be explicit. One successful test against one device build does not prove that every deployed version combination behaves the same way.
The Happy Path Works but the Safe Failure Path Is Undefined
Device disconnection, stale measurements, corrupt data, partial uploads, battery or sensor problems, unavailable cloud services, failed updates, and uncertain algorithm outputs need visible handling. The system should fail into a defined safe or supportable state instead of hiding uncertainty behind a normal-looking screen.
Cybersecurity Is Added After Functional Testing
Connected medical-device software can introduce authentication, authorization, update, network, third-party component, vulnerability, and data-integrity risks. Security architecture, dependency inventory, update mechanisms, logging, monitoring, and remediation planning should be considered as lifecycle responsibilities rather than a final penetration-test task.
Medical Device Software Capabilities We Can Plan and Engineer
The exact engineering boundary depends on the device, intended use, quality system, target market, required evidence, and which parts of the product already exist. The goal is to build the software functions and connected product layers that Digixvalley can responsibly engineer while integrating with the client, device manufacturer, clinical experts, quality team, and regulatory specialists responsible for the complete medical-device program.
Software as a Medical Device (SaMD) Products
Plan and build software whose medical purpose can operate independently of a hardware medical device, such as defined analysis, measurement, monitoring, or decision-support functions. The project should define the input data, medical purpose, user, output, limitations, review workflow, risk controls, and evidence expected for the intended market.
Companion Applications for Connected Medical Devices
Create patient or clinician applications that pair with a device, display approved information, configure permitted settings, guide workflows, collect contextual data, or coordinate synchronization. The companion app should not silently assume control or diagnostic responsibility that belongs to the device unless that function is explicitly within the approved product boundary.
Device Data Acquisition and Connectivity Layers
Integrate with supported device interfaces, gateways, SDKs, APIs, or communication protocols to acquire measurements and device status. The architecture should preserve device identity, timestamp, units, signal quality, source version, synchronization state, and communication errors so downstream users can distinguish a trustworthy measurement from stale or incomplete data.
Clinician Review and Monitoring Interfaces
Design professional workflows for reviewing device data, trends, alerts, analysis results, annotations, acknowledgements, and follow-up actions. The interface should make the source and status of information clear and should not present a derived result as a confirmed clinical interpretation unless the approved workflow supports that responsibility.
Cloud, Backend, and Device-Fleet Services
Build supporting services for device registration, secure data exchange, configuration, tenant or organization boundaries, software compatibility, monitoring, event history, notifications, and controlled operational administration. Device-fleet management should distinguish product operations from clinical record ownership.
Healthcare and Clinical-System Integrations
Connect approved device or analysis outputs with EHR/EMR, telehealth, patient portals, imaging, laboratory, identity, or analytics systems when those interfaces are part of the product. Integration scope should define which system is authoritative and whether data is displayed, imported, reconciled, or written back.
Medical Imaging and Structured Clinical Data Workflows
When the product uses imaging or other structured clinical data, plan the exact formats, metadata, identifiers, storage, review states, and interoperability requirements. DICOM, FHIR, HL7, or proprietary interfaces may be relevant depending on the product, but standards should be chosen for a real exchange responsibility rather than added as a keyword list.
Legacy Medical Software Modernization
Modernize aging medical-device or device-connected software without losing validated behavior, device compatibility, historical records, safety controls, or release evidence. Modernization may require staged architecture changes, interface adapters, regression baselines, parallel verification, controlled migration, and a carefully bounded release sequence.
For broader non-device healthcare products such as scheduling, patient access, telehealth, or care operations, see our Healthcare App Development services.
Administrative and Operational Functions
Scheduling, user administration, support workflows, general reporting, content, and non-clinical logistics may support the product without performing a medical purpose. They still require privacy, reliability, and security, but they should not be described as device functions simply because they exist inside a medical product.
Display, Transfer, and Companion Functions
A companion application may display device information, transfer data, or guide a user through an approved workflow. The project should confirm whether the software only communicates information or whether it analyzes, transforms, controls, or changes how a device performs its medical purpose.
Monitoring, Analysis, and Patient-Specific Results
Software that analyzes device or patient data can create a different responsibility from software that simply stores or transfers it. The team should define the input quality, calculation or algorithm, output meaning, intended user, decision context, uncertainty, and what happens when data is missing or inconsistent.
Diagnosis, Treatment, Therapy, or Clinical Recommendations
Functions that influence diagnosis, treatment, therapy, or patient-specific clinical decisions require much stronger intended-use, risk, evidence, validation, human-factors, and regulatory planning. They should not be introduced as an ordinary AI or analytics feature.
Medical-Device Control Functions
Software that changes a device setting, mode, energy delivery, measurement behavior, or other medical-device operation can create direct safety responsibility. Authorization, command confirmation, connectivity loss, timeout, rollback, incompatible-version behavior, and safe-state rules should be explicitly designed and tested.
Start With the Software Function and Intended-Use Boundary
Medical-device responsibility is function-specific. One product can contain administrative, communication, device-connectivity, analytical, and potentially regulated medical-device functions at the same time. Those functions should be separated so the higher-risk responsibility does not become vague and lower-risk modules do not inherit unnecessary claims.
The Device, Data, and Version Model Behind Traceable Software
A medical-device software product needs more than a patient record or application user model. It must preserve which device produced data, which software and algorithm version processed it, what quality or validity state applied, what result was shown, who reviewed it, and what action followed. That lineage supports troubleshooting, verification, investigation, and controlled change.
Raw Measurement vs Derived Result vs Clinical Interpretation
A sensor reading, a software-derived metric, an algorithmic classification, and a clinician interpretation are related but different objects. The product should preserve each layer and its source rather than overwriting raw information with the latest derived value.
Device Identity and Configuration Context
Measurements should remain connected to the device instance, configuration, calibration or setup context available to the software, and relevant hardware or firmware version. Without that relationship, reproducing an issue or comparing results across deployments becomes harder.
Software and Algorithm Version Provenance
A result should be traceable to the software, ruleset, algorithm, model, or configuration version that produced it. If an algorithm changes, teams need to know which historical results came from the previous version and whether any reprocessing is allowed or appropriate.
Validity, Signal Quality, and Uncertain Data
Missing packets, motion artifacts, sensor disconnection, stale timestamps, out-of-range values, or unsupported device versions should not automatically produce a normal-looking result. Quality flags and uncertainty should remain visible to the software and, where appropriate, to the user.
Alert, Review, and Acknowledgement State
An alert being generated is not the same as being seen, reviewed, acknowledged, escalated, or resolved. The system should preserve those transitions when the intended workflow depends on human review or operational follow-up.
Correction, Reprocessing, and Audit History
If data is corrected, reprocessed, relabeled, or invalidated, the system should preserve the prior state and explain the reason. Silent replacement makes it difficult to reconstruct what users actually saw at a particular point in time.
Architecture Decisions That Shape Medical Device Software
Medical-device architecture should be driven by intended use, failure effects, device connectivity, latency, data quality, update responsibility, cybersecurity, and evidence needs before the team chooses a framework or cloud service. These decisions determine how safely the product behaves when connected components are imperfect.
On-Device, Edge, or Cloud Processing?
Processing close to the device can reduce latency and dependency on connectivity, while cloud services can simplify centralized updates, aggregation, and computational scale. The correct split depends on the medical function, timing requirements, safe behavior during disconnection, privacy, device capability, and whether results must remain available offline.
SaMD, Companion Software, or Device-Control Layer?
A standalone analytical product, a companion application, and software that controls a hardware medical device require different architecture and risk boundaries. The team should identify which layer owns the medical purpose and which layers only transport, display, configure, or support it.
Real-Time Streaming or Store-and-Forward?
Some products need continuous or near-real-time signals, while others can upload a session for later review. Streaming adds connectivity, buffering, ordering, clock, packet-loss, and recovery problems. Store-and-forward adds completeness, upload integrity, delayed review, and synchronization questions.
Deterministic Logic or AI/ML?
Rules and deterministic algorithms are easier to reproduce, while machine-learning models may capture complex patterns but introduce training-data, performance, drift, subgroup, explainability, and change-management concerns. The choice should follow the intended use and evidence strategy rather than novelty.
Device Compatibility and Version Strategy
Define which hardware, firmware, operating-system, SDK, app, cloud API, and model versions are supported together. Compatibility rules, blocked combinations, upgrade sequencing, rollback, and end-of-support behavior should be designed before a distributed product accumulates many deployed versions.
Safe Degradation, Offline Behavior, and Recovery
When a device disconnects, the cloud is unavailable, an update fails, or input quality becomes unacceptable, the product needs a defined state. The interface should distinguish unavailable, stale, incomplete, invalid, pending, and recovered data so users do not mistake degraded operation for a normal result.
Cybersecurity and Third-Party Software Lifecycle
Threat modelling, authentication, authorization, secure communication, software update integrity, dependency inventory, vulnerability monitoring, logging, and remediation should reflect the product risk. For applicable U.S. cyber-device submissions, software-component transparency and lifecycle cybersecurity documentation can become part of the regulatory evidence, so dependency management should be planned early.
Medical Device Software Integrations and External Systems
Integration planning should define the data domain, source of truth, identifiers, supported operation, latency, failure behavior, version compatibility, and evidence needed for every connection. A successful API call is not enough if the product cannot explain whether the data is complete, current, correctly matched, and safe to use.
Medical Devices, Sensors, Gateways, and Vendor SDKs
Confirm the exact device models, firmware versions, pairing or discovery behavior, supported measurements, data rates, timestamps, units, SDK or API terms, disconnect behavior, and test hardware. Device simulation can accelerate development but does not replace testing with the supported physical configurations.
EHR / EMR and Clinical Systems
FHIR, HL7 v2, proprietary APIs, interface engines, or secure files may provide patient identity, encounter context, orders, or downstream record integration. The product should preserve source-system identifiers and should write back only the approved results or statuses supported by the clinical workflow.
Imaging and DICOM Ecosystems
If the product acquires, processes, stores, or displays medical images, DICOM workflows, metadata, series/study relationships, transfer behavior, storage, viewer compatibility, and image-processing provenance may become central design inputs. Imaging scope should be treated as a real subsystem, not a single connector.
Identity, SSO, and Organization Access
Patients, clinicians, technicians, administrators, service engineers, and support users may require different authentication and authorization. Clinical access, device servicing, support investigation, and system administration should be separated so technical convenience does not create unnecessary access to patient or device data.
Analytics, Monitoring, and Product Operations
Operational telemetry can help teams monitor service health, device connectivity, synchronization delays, software versions, failures, and support demand. Product analytics should remain distinguishable from clinical results, and sensitive data should be limited to what the monitoring purpose actually requires.
Research, Data, or Model Pipelines
If production data supports research or model improvement, the architecture should define consent or authorization, de-identification or pseudonymization where appropriate, dataset versioning, provenance, exclusion rules, labeling responsibility, and the separation between research outputs and released medical-device behavior.
Where a custom healthcare backend is needed for device registration, data exchange, integrations, and controlled services, see our Backend Development services.
Requirements-to-Risk-to-Test Traceability
A high-value traceability chain connects intended use and user needs to software requirements, identified risks, risk controls, architecture or implementation, verification tests, validation evidence, and released versions. The purpose is not document volume; it is the ability to explain why a requirement exists and how the team knows the released software satisfies it.
Verification and Validation Are Related but Not Interchangeable
Verification checks whether specified requirements were implemented correctly. Validation evaluates whether the product satisfies intended use and user needs in its intended context. A complete medical-device software program may require both, along with clinical or other evidence depending on the product. Passing software tests alone does not equal regulatory clearance.
Risk Management Should Change the Software
Risk analysis should produce concrete controls: input validation, authorization, safe limits, redundancy, state checks, warnings, confirmation, alarm behavior, logging, recovery, or other mitigations. A risk file that never changes requirements, architecture, or tests is disconnected from engineering.
Usability and Human Factors Affect Safety
Critical actions, alarms, confirmation flows, user roles, terminology, visibility of stale or uncertain data, and recovery from mistakes should be tested with the intended users and use environment. A technically correct interface can still create use-related risk if important states are hard to distinguish.
Quality-System and Regulatory Responsibilities Must Be Explicit
Depending on market and product, teams may need to work within processes aligned with frameworks such as IEC 62304, ISO 14971, IEC 62366-1, ISO 13485, FDA requirements, EU medical-device requirements, or other local controls. Digixvalley should engineer to the approved project requirements but should not imply certification, regulatory approval, or manufacturer status that has not been independently established.
Post-Release Change and Field Issues Need a Controlled Path
Bug fixes, cybersecurity updates, library upgrades, device compatibility changes, algorithm changes, and new features may affect risk, verification, validation, documentation, or regulatory obligations. The team should define change assessment, release evidence, rollout, rollback, monitoring, and support before post-launch maintenance begins.
Safety, Quality, Traceability, and Verification Must Be Engineered Together
Medical-device software quality is not created by adding a compliance checklist after development. Applicable standards, regulatory controls, quality-system procedures, and evidence expectations should be supplied or confirmed by the product owner and qualified regulatory/quality specialists, then translated into an engineering lifecycle with explicit ownership and records.
Define the Software Responsibility Before Choosing the Build Strategy
Share the intended medical purpose, target users, device or sensor inputs, required outputs or control functions, current hardware and software, target markets, quality-system context, evidence expectations, integrations, and release goals so the real build boundary can be defined before estimates are locked.
Where AI and Machine Learning Fit in Medical Device Software
AI can support medical-device products, but the closer a model moves to patient-specific measurement, diagnosis, treatment, or device control, the more important intended use, evidence, reproducibility, human oversight, monitoring, and controlled change become. Broader AI engineering can be evaluated through our AI Development services.
Data Preparation and Signal Processing
Machine learning can support denoising, segmentation, feature extraction, motion analysis, image processing, or other data transformation when the intended function and validation strategy are defined. Training and evaluation datasets should preserve provenance, labeling methods, inclusion/exclusion logic, and version history.
Classification, Prediction, and Patient-Specific Outputs
A model that produces a clinical score, classification, alert, recommendation, or prediction should have an explicit user, decision context, output meaning, limitation, error profile, and escalation path. The interface should not present probability as certainty or hide conditions in which the model is not intended to be used.
Model Versioning and Reproducibility
Production results should be traceable to the model and preprocessing version that created them. When a model changes, teams should know whether historical results remain valid, whether revalidation is required, and how the new version is rolled out across device, app, and cloud components.
Human Review and Override
Where a clinician or trained user is part of the intended workflow, the system should show enough source context, result state, uncertainty, and relevant evidence to support review. Human oversight should be designed as an actual workflow, not added as a disclaimer below an automated decision.
Performance Monitoring and Controlled Change
Post-release monitoring may need to detect technical failures, data drift, unexpected input distributions, subgroup performance issues, changes in device data quality, or altered user behavior. Model updates should follow the approved change and evidence process instead of being deployed like ordinary content changes.
For model engineering, evaluation, and AI system architecture outside the medical-device page boundary, see our AI Development services.
Use an Existing Platform, Integrate, Modernize, or Build Custom?
Custom development is not automatically the right answer for every medical-device program. The decision depends on the intended function, existing device ecosystem, validated components, product differentiation, evidence burden, cybersecurity responsibility, required integrations, and whether the organization is prepared to own a regulated software lifecycle.
| Approach | Best Fit | Main Advantages | Main Limitations |
|---|---|---|---|
| Use an existing device platform | The vendor already supports the required device workflow, data, deployment model, and target market | Fastest route, mature device compatibility, less custom lifecycle responsibility | UX, data access, workflow, evidence, integration, roadmap, and vendor limits remain |
| Integrate a proven component / SDK | A device, algorithm, viewer, connectivity layer, or service can satisfy a bounded function | Reduces custom scope and can leverage existing validation or vendor expertise where appropriate | Version compatibility, licensing, cybersecurity, supplier evidence, integration testing, and change notifications become dependencies |
| Modernize existing medical software | The current product has valuable validated behavior but aging architecture, UI, libraries, integrations, or infrastructure | Preserves product knowledge and installed workflows while addressing technical debt | Regression risk, equivalence, migration, revalidation, compatibility, and phased release require careful planning |
| Build custom medical-device software | The intended function, workflow, device ecosystem, algorithm, product IP, or operating model is materially differentiated | Purpose-built architecture, explicit data and state model, product control, custom integrations, and long-term ownership | Highest responsibility for risk controls, traceability, verification, validation, cybersecurity, documentation, regulatory inputs, and maintenance |
Planning a Medical Device Software Implementation
A credible estimate begins with product responsibility and evidence, not screen count. The project team should understand who is legally and operationally responsible for the device, what quality and regulatory process governs the work, which hardware and data sources exist, and what must be demonstrated before the software can be released.
Intended Use, Users, Patient Population, and Use Environment
Document what the product is intended to do, who uses it, for whom, under what conditions, and how the output or device action is expected to influence care. Identify contraindicated or unsupported use conditions and the environments in which connectivity, lighting, motion, noise, or other factors can affect performance.
Regulatory Path and Quality-System Inputs
Identify target countries, device or software classification decisions, applicable standards, submission strategy, design/development procedures, document templates, review gates, and regulatory responsibilities with the qualified experts responsible for those decisions. Engineering should not guess the regulatory path from a feature list.
Device Hardware, Firmware, Test Equipment, and Interfaces
List supported device models, prototype maturity, firmware versions, communication interfaces, vendor SDKs, test fixtures, simulators, calibration or setup requirements, and physical hardware availability. Delayed device access can become a critical schedule dependency.
Data, Algorithm, and Clinical-Evidence Inputs
Define the source and quality of data, preprocessing, labels, reference standards, algorithm or model responsibility, expected performance criteria, clinical evaluation inputs, and any external experts needed. A model cannot be validated responsibly when the dataset and intended decision context are still changing.
Traceability, Verification, Validation, and Documentation Ownership
Agree which artifacts the software team creates, which quality or regulatory team reviews or approves, how requirements map to risks and tests, what automated and manual evidence is required, and who owns final validation and submission documentation. This prevents gaps between engineering and quality teams.
Cybersecurity, Privacy, and Update Strategy
Map trust boundaries, identities, roles, device communication, cloud services, sensitive data, third-party software, update channels, vulnerability response, monitoring, and end-of-support expectations. Define how urgent security fixes can be assessed and released without bypassing the approved change process.
Release, Deployment, Support, and Post-Market Operations
Define where the software runs, how devices are enrolled, how versions are deployed, whether releases are phased, what data is monitored, how complaints or field issues reach engineering, who can disable or roll back a version, and how support teams investigate problems without uncontrolled access to patient data.
What Affects Medical Device Software Cost and Timeline?
Fixed public estimates can be misleading because medical-device programs vary substantially in safety responsibility, hardware maturity, evidence, integration, quality-system, validation, and market-access requirements. Estimate the software from the variables that actually change engineering and verification effort.
Intended Use and Risk of the Software Function
Administrative support is a different scope from software that analyzes patient-specific data, recommends treatment, or controls a medical device. Higher-consequence functions generally require deeper hazard analysis, risk controls, verification, validation, documentation, specialist input, and review.
Hardware and Connectivity Complexity
One mature device with a stable SDK is different from multiple device models, firmware versions, Bluetooth or network conditions, intermittent connections, custom protocols, or incomplete prototype hardware. Compatibility and test-matrix size can materially change effort.
Quality-System and Evidence Requirements
The amount of controlled documentation, review, traceability, risk management, verification evidence, validation, supplier evidence, release records, and submission support depends on the product and operating organization. Existing quality-system maturity can reduce ambiguity but may also introduce required procedures and review gates.
Clinical, Imaging, and Healthcare Integrations
DICOM, EHR/EMR, FHIR, HL7, identity, lab, cloud, device-vendor, or hospital-network integrations add data mapping, security, sandbox, validation, failure handling, partner, and deployment dependencies. Enterprise clinical environments can also require lengthy access and onboarding processes.
AI / ML and Data-Evidence Scope
Model training, expert labeling, clinical reference data, subgroup evaluation, explainability, robustness, reproducibility, drift monitoring, and controlled model changes can add significant work beyond ordinary software development.
Cybersecurity and Third-Party Components
Threat modelling, secure update design, SBOM or dependency records where applicable, penetration testing, vulnerability management, supplier review, and long-term patch responsibilities can affect architecture and ongoing operating cost.
Markets, Device Variants, and Rollout Strategy
Supporting multiple jurisdictions, hardware variants, languages, care environments, operating systems, or organizations expands the verification and configuration matrix. Phased rollout can reduce launch risk but adds parallel version and support planning.
For an early directional software estimate before a regulated scope is fully validated, use the software development cost calculator as a starting point, then refine the estimate from the device-specific inputs above.
Requirements, Risk Controls, and Traceability Review
Confirm that safety-relevant requirements have owners, rationale, source, implementation, and verification evidence. Changes should update the traceability chain so the team can see which risks and tests are affected before a release candidate is approved.
Device and Version Compatibility Testing
Test the supported hardware, firmware, app, operating-system, cloud, interface, and algorithm combinations rather than one ideal configuration. Include unsupported-version behavior, failed pairing, interrupted sessions, update problems, stale configuration, and rollback or recovery where applicable.
Failure, Boundary, and Data-Integrity Testing
Simulate device disconnects, corrupt or incomplete input, delayed data, duplicated messages, clock problems, partial uploads, unavailable cloud services, invalid user roles, out-of-range values, and uncertain algorithm outputs. High-risk failures should be visible and recoverable rather than silently normalized.
Verification, Validation, and Usability Evidence
Maintain software verification against requirements and separate validation/usability evidence appropriate to the intended use and quality plan. Testing should include realistic users, environments, workflows, and device conditions where the approved strategy requires them.
Controlled Deployment and Post-Release Monitoring
Use controlled release, monitoring, compatibility checks, rollback, issue triage, vulnerability response, and change assessment appropriate to the product. Post-launch engineering can be planned through Digixvalley application maintenance and support services without treating regulated change like an ordinary consumer-app update.
For modernization of an existing product that must preserve behavior while changing architecture or dependencies, see our Application Modernization services.
From Intended-Use Discovery to Controlled Release
Medical-device software should be built and tested through an evidence-aware lifecycle. The exact regulated process belongs to the manufacturer and its quality/regulatory system, but the software delivery plan should make requirements, risks, interfaces, verification, validation, changes, and release decisions visible from the start.
Relevant Healthcare Product Experience
Healthcare proof should be tied to the workflows and technical responsibilities documented in each case study. A telehealth project should not be treated as evidence of EHR implementation or medical-device compliance unless those elements are explicitly verified.
Remote Dental Care - Healthcare Platform Planning and Multi-Role Telehealth Workflows
The Remote Dental Care case study describes a dental telehealth platform for patients, dentists, clinics, and administrators. Its documented scope includes remote consultations, appointment scheduling, patient management, treatment coordination, notifications, healthcare communication, analytics, role-based permissions, and mobile/web accessibility. It demonstrates healthcare workflow planning and multi-role product architecture without being used as proof of production EHR integration, HIPAA certification, or regulated clinical software.
Aletha Health - AI-Assisted Remote Physical Therapy Assessment
Digixvalley published Aletha Health case study describes AI-powered motion tracking and remote patient assessment for physical therapy. The case study reports a 38% increase in remote patient assessments and a 25% improvement in patient retention. It is relevant evidence for remote-care product thinking, computer vision, motion analysis, and patient-facing accessibility, while broader clinical validation or regulatory claims should not be inferred beyond the published scope.
Explore Our Profiles, Reviews, and Case Studies
Before starting review Digixvalley public profiles, case studies, and project experience to understand how we approach mobile app design, development, backend engineering, testing, and long-term support.
Clutch
Top 1000 CompaniesINC. 5000
America’s Fastest Growing CompaniesDot Comm
Excellence in Web Creativity & Digital CommunicationExpertise
Best Mobile App DeveloperSoftware World
Top App Development CompaniesHorizon Award
Gold Awards WinnerRank Watch
Top Web Development AgenciesHorizon Award
Silver Awards WinnerLatest Insights
CEO, Digixvalley
CEO, Digixvalley
Eguide
App Monetization Strategies: How to Make Money From an App?
Let’s Hear What Our Clients Say
Frequently Asked Questions
Medical-device software is software whose function meets the applicable definition of a medical device or is part of a medical-device system. Depending on jurisdiction and product architecture, teams may use terms such as device software function, Software as a Medical Device (SaMD), Software in a Medical Device (SiMD), or medical device software. The correct classification depends on intended use and the actual software function, not the label used by a vendor.
A normal healthcare app may support scheduling, communication, administration, education, or other workflows without performing a medical-device function. SaMD performs one or more medical purposes through software without being part of a hardware medical device. Intended use, patient-specific processing, clinical reliance, and applicable regulatory definitions determine the boundary.
SaMD performs its medical purpose independently of hardware medical-device functionality. Software in a medical device operates as part of, or within, a hardware medical-device system. A connected product can contain both device and non-device software functions, so the architecture should identify the responsibility of each function rather than rely on one product-wide label.
No. In the United States, FDA policy is function-specific. Many healthcare and wellness software functions are not medical devices, while some medical-device software functions may be subject to FDA oversight depending on intended use and risk. Product classification and submission requirements should be confirmed for the exact software function and market by qualified regulatory specialists.
Potentially. The project should verify the exact device models, firmware versions, communication method, SDK or API, data formats, patient and device identifiers, timing and quality states, EHR/EMR interfaces, sandbox access, security, and production environment before committing to an integration. FHIR, HL7, DICOM, proprietary APIs, vendor SDKs, or other interfaces may apply depending on the product.
Applicable standards depend on product, market, manufacturer, and regulatory strategy. Medical-device programs commonly evaluate standards and frameworks such as IEC 62304 for software lifecycle processes, ISO 14971 for medical-device risk management, IEC 62366-1 for usability engineering, ISO 13485 for quality-management systems, and market-specific FDA or EU requirements. Digixvalley should implement the approved engineering requirements without claiming certification or legal applicability that has not been verified.
Yes, when the product scope and quality/regulatory plan support modernization. The project should preserve validated behavior, device compatibility, risk controls, data, configuration, traceability, and release evidence while changing architecture, user experience, libraries, infrastructure, or integrations. Modernization usually needs a stronger regression and compatibility plan than an ordinary application rewrite.
AI can increase the evidence and lifecycle scope when it influences patient-specific measurement, classification, diagnosis, treatment, or device behavior. The project may need stronger dataset provenance, performance evaluation, reproducibility, subgroup analysis, human oversight, model versioning, drift monitoring, and controlled change. AI should not be added as a generic feature without defining its intended medical role.
Software engineering can support a client program with requirements, architecture, traceability, implementation, testing, technical documentation, cybersecurity, and evidence activities defined by the approved project process. Regulatory classification, certification, clinical evaluation, manufacturer obligations, quality-system certification, submission decisions, and final approval remain responsibilities of the appropriate product owner, quality, clinical, legal, and regulatory experts unless a separately verified engagement explicitly assigns them.
The main drivers are intended use and risk, number of software functions, hardware maturity, device and firmware variants, connectivity, clinical and healthcare integrations, quality-system requirements, verification and validation depth, cybersecurity, documentation, data and AI evidence, target markets, partner onboarding, and release strategy.
Current Digixvalley custom-development pages state that clients receive source-code ownership and relevant project documentation for custom builds. Exact intellectual-property transfer, repository access, build systems, infrastructure, third-party components, device SDK licenses, credentials, documentation, test artifacts, deployment assets, and handover terms should be defined in the project agreement for the specific engagement.
Build Medical Device Software Around Intended Use, Risk, Evidence, and Controlled Change
Define the medical purpose, software functions, device interfaces, patient and user context, quality-system inputs, risk controls, data lineage, verification and validation, cybersecurity, target markets, and post-release responsibilities before architecture and estimates are locked.